SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-039178
Filing Date
2021-07-29
Accepted
2021-07-29 16:44:35
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-10q_20210630.htm   iXBRL 10-Q 2389213
2 EX-10.1 crsp-ex101_103.htm EX-10.1 36840
3 EX-10.2 crsp-ex102_184.htm EX-10.2 26359
4 EX-31.1 crsp-ex311_9.htm EX-31.1 19315
5 EX-31.2 crsp-ex312_11.htm EX-31.2 19521
6 EX-32.1 crsp-ex321_8.htm EX-32.1 8423
7 GRAPHIC gaohwwcqhi4e000001.jpg GRAPHIC 6572
  Complete submission text file 0001564590-21-039178.txt   9268485

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA crsp-20210630.xsd EX-101.SCH 56519
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20210630_cal.xml EX-101.CAL 54076
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20210630_def.xml EX-101.DEF 184157
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20210630_lab.xml EX-101.LAB 430882
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20210630_pre.xml EX-101.PRE 310782
13 EXTRACTED XBRL INSTANCE DOCUMENT crsp-10q_20210630_htm.xml XML 2027558
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 211128127
SIC: 2836 Biological Products, (No Diagnostic Substances)